Phospho-P70 S6 Kinase β/SRK (Ser371) Antibody

About the Target

P70 S6 Kinase Β/SRK is a target of interest in many antibody-based workflows. Phospho-P70 S6 Kinase β (Ser 371) is the phosphorylated form of the P70 S6 kinase β isoform (S6K2 or SRK) at serine 371, a critical regulatory site that significantly influences the kinase's activation and downstream signalling functions. This phosphorylation is essential within the mTOR signalling pathway, which governs protein synthesis, cell growth, and cell cycle progression in response to growth factors and nutrient availability. Depending on the literature source, P70 S6 Kinase Β/SRK may also be discussed as Phospho-P70 S6 Kinase beta/SRK (Ser371) and P70 S6 Kinase beta/SRK (phospho S371).

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following P70 S6 Kinase Β/SRK across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

P70 S6 Kinase Β/SRK is commonly interpreted in the context of cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• differences between total target abundance and site-specific regulation when modified forms are compared
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for P70 S6 Kinase Β/SRK. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in P70 S6 Kinase Β/SRK reflect biology rather than handling. When interpreting P70 S6 Kinase Β/SRK, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep P70 S6 Kinase Β/SRK trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.